Sexual dysfunction in first-episode schizophrenia patients: Results from european first episode schizophrenia trial

Journal of Clinical Psychopharmacology

Volumn 31, Issue 3, 2011, Pages 274-280

  Malik, Peter ^a   Kemmler, Georg ^a   Hummer, Martina ^a   Riecher Roessler, Anita ^b   Kahn, René S ^c   Fleischhacker, W Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

amenorrhea; amisulpride; first episode schizophrenia; prolactin; sexual dysfunction

Indexed keywords

AMISULPRIDE; HALOPERIDOL; OLANZAPINE; PROLACTIN; QUETIAPINE; ZIPRASIDONE;

ADULT; AMENORRHEA; ARTICLE; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FEMALE; FEMALE SEXUAL DYSFUNCTION; FIRST EPISODE SCHIZOPHRENIA; GALACTORRHEA; GROUPS BY AGE; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MENORRHAGIA; ORGASM DISORDER; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA; SEXUAL FUNCTION; VAGINAL DRYNESS;

ADOLESCENT; ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 79955589132     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182199bcc     Document Type: Article

References (47)

1. Westheide J, Cohen S, Bender S, et al. Sexual dysfunction in psychiatric inpatients: the role of antipsychotic medication. Pharmacopsychiatry. 2007;40(4):140-145. (Pubitemid 47434871)
2. Macdonald S, Halliday J, MacEwan T, et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction: case-control study. Br J Psychiatry. 2003;182:50-56. (Pubitemid 36132419)
3. Howes OD, Wheeler MJ, Pilowsky LS, et al. Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2007;68(3):361-367. (Pubitemid 46506799)
4. Lambert M, Conus P, Eide P, et al. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry. 2004;19(7):415-422. (Pubitemid 39422495)
5. Olfson M, UttaroT, CarsonWH, et al. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry. 2005;66(3):331-338. (Pubitemid 40476756)
6. Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol. 2008;23(3):201-209. (Pubitemid 351577689)
7. Knegtering H, van der Moolen AE, Castelein S, et al. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology. 2003;28(suppl 2):109-123. (Pubitemid 36335820)
8. Smith S. Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice. J Clin Psychopharmacol. 2003;23(3 suppl 1):S27-S32. (Pubitemid 36807785)
9. Hummer M, Huber J. Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Curr Med Res Opin. 2004;20(2):189-197. (Pubitemid 38197320)
10. Cutler AJ. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology. 2003;28(suppl 1):69-82. (Pubitemid 36015662)
11. Bancroft J. Endocrinology of sexual function. Clin Obstet Gynaecol. 1980;7:253-281. (Pubitemid 11216765)
12. Costa AM, de Lima MS, Faria M, et al. A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia. J Psychopharmacol. 2007;21(2):165-170. (Pubitemid 46280467)
13. Berwaerts J, Cleton A, Rossenu S, et al. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia [published online ahead of print October 13, 2009]. J Psychopharmacol. 2010;24(7):1011-1018.
14. Segraves RT. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry. 1989;46(3):275-284. (Pubitemid 19078265)
15. Montejo AL, Majadas S, Rico-Villademoros F, et al. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med. 2010;7(10):3404-3413.
16. Canuso CM, Goldstein JM, Wojcik J, et al. Antipsychotic medication, prolactin elevation, and ovarian function inwomen with schizophrenia and schizoaffective disorder. Psychiatry Res. 2002;111:11-20. (Pubitemid 34879071)
17. Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry. 2002;181:49-55. (Pubitemid 34717838)
18. Knegtering R, Castelein S, Bous H, et al. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol. 2004;24:56-61. (Pubitemid 38139316)
19. Knegtering H, van den Bosch R, Castelein S, et al. Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? Psychoneuroendocrinology. 2008;33(6):711-777.
20. Rettenbacher MA, Baumgartner S, Ebenbichler C, et al. Prolactin levels and sexual side effects in schizophrenia patients during antipsychotic treatment. J Clin Psychopharmacol. 2010;30(6):711-715.
21. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, et al. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry. 1995;56:137-141.
22. Fleischhacker WW. Tolerability of antipsychotics: recent controversies and future management. J Clin Psychiatry. 2009;70(3):e06.
23. FleischhackerWW, Keet IP, Kahn RS. EUFEST Steering Committee. The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial. Schizophr Res. 2005;78(2-3):147-156. (Pubitemid 41254018)
24. Kahn RS, Fleischhacker WW, Boter H, et al. EUFEST study group. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008;371(9618):1085-1097. (Pubitemid 351418005)
25. Kay SR, Fiszbein A, OplerLA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. (Pubitemid 18039085)
26. Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1-100. (Pubitemid 17115352)
27. Gerlach J, Korsgaard S, Clemmesen P, et al. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand. 1993;87(4):244-252. (Pubitemid 23107274)
28. Diggle PJ, Heagerty P, Liang K, et al. Analysis of Longitudinal Data. 2nd ed. Oxford: Oxford University Press; 2002.
29. van Bruggen M, van Amelsvoort T, Wouters L, et al. Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone. Psychoneuroendocrinology. 2009;34(7):989-995.
30. Montejo González AL, Rico-Villademoros F, Tafalla M, et al; Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. A 6-month prospective observational study on the effects of quetiapine on sexual functioning. J Clin Psychopharmacol. 2005;25(6):533-538. (Pubitemid 41669044)
31. Hanssens L, L'Italien G, Loze JY, et al. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry. 2008;8:95.
32. Rossi A, Vita A, Tiradritti P, et al. Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. Int Clin Psychopharmacol. 2008;23(4):216-222.
33. Montejo AL, Rico-Villademoros F, Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study. J Clin Psychopharmacol. 2008;28:568-570.
34. Dossenbach M, Dyachkova Y, Pirildar S, et al. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry. 2006;21(4):251-258. (Pubitemid 43929245)
35. Montejo AL, Rico-Villademoros F, Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther. 2008;34:227-239. (Pubitemid 351507750)
36. Montejo AL, Riesgo Y, Luque J, et al; Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole [published online ahead of print January 1, 2010]. Actas Esp Psiquiatr. 2010;38(1):13-21.
37. Mortimer A, Martin S, Lôo H, et al; SOLIANOL Study Group. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia. Int Clin Psychopharmacol. 2004;9(2):63-69. (Pubitemid 38316764)
38. Kropp S, Ziegenbein M, Grohmann R, et al. Galactorrhea due to psychotropic drugs. Pharmacopsychiatry. 2004;37(suppl 1):S84-S88. (Pubitemid 38658335)
39. Hummer M, Kemmler G, Kurz M, et al. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry. 1999;56(4):631-633. (Pubitemid 29162987)
40. Aizenberg D, Modai I, Landa A, et al. Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry. 2001;62(7):541-544. (Pubitemid 32703094)
41. Wirshing DA, Pierre JM, Marder SR, et al. Sexual side effects of novel antipsychotic medications. Schizophr Res. 2002;56(1-2):25-30. (Pubitemid 34655464)
42. Konarzewska B, Woaczycski S, Szulc A, et al. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Psychoneuroendocrinology. 2009;34(1):129-139.
43. Riecher-Rössler A, Häfner H. Schizophrenia and oestrogensVis there an association? Eur Arch Psychiatry Clin Neurosci. 1993;242:323-328.
44. Montejo AL. Prolactin awareness: an essential consideration for physical health in schizophrenia. Eur Neuropsychopharmacol. 2008;18(suppl 2):S108-S114.
45. Low D, Cable T, Purvis A. Exercise thermoregulation and hyperprolactinemia. Ergonomics. 2005;48(11-14):1547-1557.
46. Fan X, Henderson DC, Chiang E. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res. 2007;94:(1-3):119-127. (Pubitemid 47031603)
47. Westheide J, Cvetanovska G, Albrecht C, et al. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone. J Sex Med. 2008;5(12):2816-2826.